U.K. Pharmaceuticals & Biotech Big Green Snowflakes

Solvonis Therapeutics

Market Cap: UK£22.3m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

ValiRx

Market Cap: UK£2.2m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Ananda Pharma

Market Cap: UK£11.8m

Ananda Pharma Plc, along with its subsidiaries, operate as a biopharmaceutical company that develops cannabidiol-based medicine to treat endometriosis and chemotherapy-induced peripheral neuropathy chronic conditions across the United Kingdom and internationally.

Roquefort Therapeutics

Market Cap: UK£3.3m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Aptamer Group

Market Cap: UK£20.2m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

CRISM Therapeutics

Market Cap: UK£3.8m

Develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs.

ImmuPharma

Market Cap: UK£56.8m

A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.

AIM ImmunoTech

Market Cap: US$7.6m

An immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States.

Cizzle Biotechnology Holdings

Market Cap: UK£5.9m

Operates as a cancer diagnostics company in the United Kingdom.

Arecor Therapeutics

Market Cap: UK£32.7m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Tissue Regenix Group

Market Cap: UK£9.4m

A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.

Proteome Sciences

Market Cap: UK£5.8m

Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.

Palatin Technologies

Market Cap: US$8.0m

A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.

Hemogenyx Pharmaceuticals

Market Cap: UK£62.3m

A clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of treatments for blood cancer.

Genflow Biosciences

Market Cap: UK£6.8m

Engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium.

Avacta Group

Market Cap: UK£231.3m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

Scancell Holdings

Market Cap: UK£101.2m

A clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom.

Allergy Therapeutics

Market Cap: UK£402.8m

A commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders.

Hellenic Dynamics

Market Cap: UK£1.4m

Engages in the cultivation and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers in Europe.

Cardiogeni

Market Cap: UK£8.0m

A clinical stage biotechnology company, develops heart failure medicines.